P01050 (HIRV1_HIRME) Hirudo medicinalis (Medicinal leech)
Hirudin variant-1 UniProtKBInterProInteractive Modelling
65 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
91 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure for the complex of thrombin mutant D102N and hirudin |
Heteromer P00734; | 100.0 | 1×NA; 1×NAG; 3×ACT; | |||
| The Crystal Structure of Bovine Thrombin in complex with Hirudin (C22U/C39U) at 2.7 Angstroms Resol… |
Heteromer P00735; | 96.92 | 1×NAG; 1×NA; | |||
| THE STRUCTURE OF A COMPLEX OF BOVINE ALPHA-THROMBIN AND RECOMBINANT HIRUDIN AT 2.8 ANGSTROMS RESOLU… |
Heteromer P00735; | 100 | ||||
| The Crystal Structure of Bovine Thrombin in complex with Hirudin (C16U/C28U) at 1.6 Angstroms Resol… |
Heteromer P00735; | 96.88 | 1×NAG; 1×NA; | |||
| The Crystal Structure of Bovine Thrombin in complex with Hirudin (C6U/C14U) at 1.9 Angstroms Resolu… |
Heteromer P00735; | 96.88 | 1×NAG; 1×NA; | |||
| Crystal structure of sulfo-hirudin complexed to thrombin |
Heteromer P00734; | 100.0 | 1×NI; 1×NA; | |||
| CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH BENZOTHIOPHENE INHIBITOR 4 |
Heteromer P00734; | 100 | 1×NAG; 2×NA; 1×BZT; | |||
| CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH 5-AMIDINOINDOLE-4-BENZYLPIPERIDINE INHIBI… |
Heteromer P00734; | 100 | 1×NAG; 2×NA; 1×BPP; | |||
| CRYSTAL STRUCTURE OF HUMAN APLHA-THROMBIN IN COMPLEX WITH BENZO[B]THIOPHENE INHIBITOR 3 |
Heteromer P00734; | 100 | 1×NAG; 2×NA; 1×BT3; | |||
| CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH BENZO[B]THIOPHENE INHIBITOR 2 |
Heteromer P00734; | 100 | 1×NAG; 2×NA; 1×BT2; | |||
| CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH BENZO[B]THIOPHENE INHIBITOR 1 |
Heteromer P00734; | 100 | 1×NAG; 2×NA; 1×BT1; | |||
| Thrombin in complex with (S)-(4-chloro-2-((1-(5-methyl-1H-pyrrole-2-carbonyl)pyrrolidine-2-carboxam… |
Heteromer P00734; | 100 | 1×MG; 1×GOL; 1×NAG; 1×45S; | |||
| Exploring Thrombin S1 pocket |
Heteromer P00734; | 100 | 2×NA; 1×PO4; 1×37U; | |||
| Exploring Thrombin S1 pocket |
Heteromer P00734; | 100 | 2×NA; 1×PO4; 1×32U; | |||
| Design of weakly basic thrombin inhibitors incorporating novel P1 binding functions: molecular and … |
Heteromer P00734; | 100 | 1×NAG; 1×4ND; | |||
| Human thrombin complexed with Napsagatran, RO0466240 |
Heteromer P00734; | 100 | 2×NA; 1×N5N; 1×NAG; | |||
| Thrombin Inhibition |
Heteromer P00734; | 100 | 2×NA; 1×27U; | |||
| Exploring Thrombin S1 Pocket |
Heteromer P00734; | 100 | 2×NA; 1×51U; | |||
| Discovery and Clinical Evaluation of RWJ-671818, a Thrombin Inhibitor with an Oxyguanidine P1 Motif |
Heteromer P00734; | 100 | 1×NLI; | |||
| Human alpha-thrombin complexed with N-(methylsulfonyl)-D-phenylalanyl-N-((1-carbamimidoyl-4-piperid… |
Heteromer P00734; | 100 | 1×0BM; | |||
| Thrombin-hirugen binary complex at 1.26A resolution |
Heteromer P00734; | 100 | 1×NA; 1×CA; | |||
| Thrombin-hirugen-gw473178 ternary complex at 1.32A resolution |
Heteromer P00734; | 100 | 1×NA; 1×CA; 1×896; | |||
| Thrombin-hirugen-gw420128 ternary complex at 1.39A resolution |
Heteromer P00734; | 100 | 1×NA; 1×CA; 1×897; | |||
| X-ray structure of the human alpha-thrombin complex with a tripeptide phosphonate inhibitor. |
Heteromer P00734; | 100 | 1×PHW; | |||
| Exploring Thrombin S1-pocket |
Heteromer P00734; | 100 | 2×NA; 1×53U; | |||
| STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKI… |
Heteromer P00734; | 100 | 1×NA; 1×CA; | |||
| Thrombin Inhibitor |
Heteromer P00734; | 100 | 1×2TS; 2×NA; | |||
| Thrombin in complex with Inhibitor |
Heteromer P00734; | 100 | 2×NA; 1×22U; | |||
| CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN COMPLEXED WITH HIRUGEN AND P-AMIDINOPHENYLPYRUVATE AT 1.6… |
Heteromer P00734; | 100 | 1×APA; | |||
| thrombin in complex with inhibitor |
Heteromer P00734; | 100 | 1×NA; 1×UNB; | |||
| Crystal Structure Analysis of thrombin in complex with compound D58 |
Heteromer P00734; | 100 | 1×NAG; 2×NA; 1×7R9; | |||
| Thrombin Inhibition |
Heteromer P00734; | 100 | 1×26U; 2×NA; 1×BEN; | |||
| Thrombin Inhibition |
Heteromer P00734; | 100 | 2×NA; 1×24U; 1×BEN; | |||
| Bisphenylic Thrombin Inhibitors |
Heteromer P00734; | 100 | 1×33U; 2×NA; | |||
| X-ray crystal structure of human alpha-thrombin with a tripeptide phosphonate inhibitor. |
Heteromer P00734; | 100 | 1×PHV; | |||
| Thrombin Inhibitor Complex |
Heteromer P00734; | 100 | 1×CCR; | |||
| Thrombin Inhibitor Complex |
Heteromer P00734; | 100 | 1×UIB; | |||
| Thrombin Inhibitor Complex |
Heteromer P00734; | 100 | 1×UIR; | |||
| Thrombin Inhibition |
Heteromer P00734; | 100 | 1×31U; 2×NA; | |||
| THROMBIN INHIBITOR FROM THEONALLA, CYCLOTHEANAMIDE-BASED MACROCYCLIC TRIPEPTIDE MOTIF |
Heteromer P00734; | 100 | 1×1ZV; | |||
| Thrombin Inhibition |
Heteromer P00734; | 100 | 2×NA; 1×29U; | |||
| Thrombin Inhibitor Complex |
Heteromer P00734; | 100 | 2×NA; 1×UIP; 3×GOL; | |||
| X-ray crystal structure of thrombin inhibited by synthetic cyanopeptide analogue RA-1014 |
Heteromer P00734; | 100 | 1×RA4; | |||
| X-ray crystal structure of thrombin inhibited by synthetic cyanopeptide analogue RA-1008 |
Heteromer P00734; | 100 | 2×NA; 1×RA8; 2×GOL; | |||
| HUMAN ALPHA-THROMBIN TERNARY COMPLEX WITH THE EXOSITE INHIBITOR HIRUGEN AND ACTIVE SITE INHIBITOR P… |
Heteromer P00734; | 100 | 1×T42; | |||
| Thrombin in complex with inhibitor |
Heteromer P00734; | 100 | 1×NAG; 1×M6S; 2×NA; | |||
| Thrombin in complex with inhibitor |
Heteromer P00734; | 100 | 1×NAG; 1×MM9; 2×NA; | |||
| Thrombin in complex with inhibitor |
Heteromer P00734; | 100 | 1×NAG; 1×M4Z; 2×NA; | |||
| Specifity for Plasminogen Activator Inhibitor-1 |
Heteromer P00734; | 100 | ||||
| Thrombin in complex with inhibitor |
Heteromer P00734; | 90.0 | 1×NAG; 1×MEL; 2×NA; | |||
| Thrombin in complex with inhibitor |
Heteromer P00734; | 90.0 | 1×NAG; 1×M67; 2×NA; | |||
| Novel Covalent Active Site Thrombin Inhibitors |
Heteromer P00734; | 100 | 1×166; | |||
| ALPHA-THROMBIN COMPLEXED WITH HIRUGEN AND PROFLAVIN |
Heteromer P00734; | 100 | 1×PRL; | |||
| COMPLEX OF THROMBIN WITH AND INHIBITOR CONTAINING A NOVEL P1 MOIETY |
Heteromer P00734; | 100 | 1×NA; 1×MDL; | |||
| HUMAN ALPHA-THROMBIN INHIBITION BY EOC-D-PHE-PRO-AZALYS-ONP |
Heteromer P00734; | 100 | 1×NAG; 1×AZL; | |||
| ALPHA-THROMBIN (HIRUGEN) COMPLEXED WITH NA-(N,N-DIMETHYLCARBAMOYL)-ALPHA-AZALYSINE |
Heteromer P00734; | 100 | 1×NAG; 2×IN2; | |||
| STRUCTURE OF THROMBIN COMPLEXED WITH SELECTIVE NON-ELECTROPHILIC INHIBITORS HAVING CYCLOHEXYL MOIET… |
Heteromer P00734; | 100 | 2×NA; 1×00R; | |||
| HUMAN ALPHA-THROMBIN INHIBITION BY CBZ-PRO-AZALYS-ONP |
Heteromer P00734; | 100 | 1×NAG; 1×ALZ; | |||
| Thrombin in complex with inhibitor |
Heteromer P00734; | 90.0 | 1×NA; 1×SN3; | |||
| Active site thrombin inhibitors |
Heteromer P00734; | 100 | 1×L02; 3×DMS; | |||
| SERINE PROTEASE |
Heteromer P00734; | 90.0 | 2×RB; | |||
| HUMAN THROMBIN COMPLEX WITH HIRUDIN VARIANT |
Heteromer P00734; | 90.0 | ||||
| Novel Covalent Active Site Thrombin Inhibitors |
Heteromer P00734; | 100 | 1×167; | |||
| NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS |
Heteromer P00734; | 100 | 1×157; | |||
| Novel Covalent Active Site Thrombin Inhibitors |
Heteromer P00734; | 100 | 1×GR1; | |||
| NOVEL COVALENT THROMBIN INHIBITOR FROM PLANT EXTRACT |
Heteromer P00734; | 100 | 1×GR4; | |||
| Thrombin in complex with an oxazolopyridine inhibitor 2 |
Heteromer P00734; | 100 | 1×501; | |||
| thrombin in complex with an oxazolopyridine inhibitor 21 |
Heteromer P00734; | 100 | 1×382; | |||
| Thrombin Inibition |
Heteromer P00734; | 100 | 2×NA; 1×19U; | |||
| Nonbasic Thrombin Inhibitor Complex |
Heteromer P00734; | 100 | 1×GAH; | |||
| STRUCTURE OF THROMBIN COMPLEXED WITH SELECTIVE NON-ELECTOPHILIC INHIBITORS HAVING CYCLOHEXYL MOIETI… |
Heteromer P00734; | 100 | 2×NA; 1×00P; | |||
| Thrombin Inhibition |
Heteromer P00734; | 100 | 2×NA; 1×BEN; | |||
| High affinity inhibitor of human thrombin |
Heteromer P00734; | 100 | 1×1TS; 2×NA; | |||
| Thrombin Inhibition |
Heteromer P00734; | 100 | 2×NA; 1×21U; | |||
| Understanding Thrombin Inhibition |
Heteromer P00734; | 100 | 1×64U; 2×NA; | |||
| Bisphenylic Thrombin Inhibitors |
Heteromer P00734; | 100 | 1×23U; 2×NA; | |||
| KNOBLE Inhibitor |
Heteromer P00734; | 100 | 1×M18; 2×NA; | |||
| Understanding Thrombin Inhibition |
Heteromer P00734; | 100 | 1×16U; 2×NA; | |||
| HUMAN ALPHA-THROMBIN COMPLEXED WITH [S-(R*,R*)]-4-[(AMINOIMINOMETHYL)AMINO]-N-[[1-[3-HYDROXY-2-[(2-… |
Heteromer P00734; | 100 | 1×BM2; | |||
| HUMAN ALPHA-THROMBIN COMPLEXED WITH [S-(R*,R*)]-1-(AMINOIMINOMETHYL)-N-[[1-[N-[(2-NAPHTHALENYLSULFO… |
Heteromer P00734; | 100 | 1×BM9; | |||
| THROMBIN INHIBITOR WITH A RIGID TRIPEPTIDYL ALDEHYDES |
Heteromer P00734; | 100 | 1×0IT; 1×NAG; | |||
| Thrombin inhibitors with rigid tripeptidyl aldehydes |
Heteromer P00734; | 100 | 2×NA; 1×0KV; | |||
| THROMBIN INHIBITORS WITH RIGID TRIPEPTIDYL ALDEHYDES |
Heteromer P00734; | 100 | 2×NA; 1×0IV; | |||
| Thrombin with 3-cycle with F |
Heteromer P00734; | 100 | 1×I26; 1×NA; 1×CA; | |||
| CHANGES IN INTERACTIONS IN COMPLEXES OF HIRUDIN DERIVATIVES AND HUMAN ALPHA-THROMBIN DUE TO DIFFERE… |
Heteromer P00734; P28504; | 50.0 | 1×NAG; | |||
| The NMR Solution Structure of Recombinant RGD-hirudin | monomer | 92.16 | ||||
| THE NMR SOLUTION STRUCTURE OF HIRUDIN(1-51) AND COMPARISON WITH CORRESPONDING THREE-DIMENSIONAL STR… | monomer | 100 | ||||
| SOLUTION STRUCTURE OF RECOMBINANT HIRUDIN AND THE LYS-47 (RIGHT ARROW) GLU MUTANT. A NUCLEAR MAGNET… | monomer | 97.96 | ||||
| SOLUTION STRUCTURE OF RECOMBINANT HIRUDIN AND THE LYS-47 (RIGHT ARROW) GLU MUTANT. A NUCLEAR MAGNET… | monomer | 100 | ||||
| SOLUTION STRUCTURE OF RECOMBINANT HIRUDIN AND THE LYS-47 (RIGHT ARROW) GLU MUTANT. A NUCLEAR MAGNET… | monomer | 97.96 | ||||
| SOLUTION STRUCTURE OF RECOMBINANT HIRUDIN AND THE LYS-47 (RIGHT ARROW) GLU MUTANT. A NUCLEAR MAGNET… | monomer | 100 | ||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7a0e.1.B | monomer | 0.75 | 96.92 | |||